ArticleGastroenterology report2025

In-depth plasma proteomics reveals the dynamic changes and prognostic biomarkers for chimeric antigen receptor-glypican-3 T-cell therapy in patients with hepatocellular carcinoma.

Xudong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.